Category Archive for Interesting Reads
For opinion pieces and round-ups
Companies lose pricing powers in Pakistan
Reports say that Prime Minister Imran Khan has instructed the Government to reform pharmaceutical pricing, removing the ability of companies … read more »
ICER delves into potential funding models for COVID-19 products
The Institute for Clinical and Economic Review (ICER) has examined a range of funding models that could be used for … read more »
SMC suspends meetings during COVID-19 pandemic
The SMC has indefinitely suspended meetings of its SMC Committee and New Drugs Committee until further notice as a result … read more »
New UK ‘RAPID-C19’ coordination body launched to support access for COVID therapies
The UK has announced a new collaboration initiative to triage, coordinate, and fast-track potential COVID-19 therapies. The RAPID-C19 (Research to … read more »
IVIg-G product approved for phase 3 COVID-19 trial
Octagam, an intravenous immunoglobulin-G (IVIg-G) product has received approval for a phase 3 trial to reduce the effects of COVID-19. … read more »
UK extends COVID-19 testing to all
Everyone in the UK with COVID-19 symptoms is now eligible for a test, previously limited to key workers, or those … read more »
Gene therapy Zolgensma granted conditional approval from the EMA
AveXis have been granted European conditional approval from the European Medicines Agency (EMA) for its spinal muscular atrophy (SMA) gene … read more »
UK COVID-19 immunity study begins
The UK government has begun a major long-term antibody study aiming to track the spread of COVID-19. The study will perform … read more »
NHS England hopes coronavirus crisis will lead to surge in nursing numbers
Sir Simon Stevens, NHS Chief Executive has celebrated International Nurses Day, saying more nursing courses should be made available to … read more »
Virtual ISPOR 2020 conference opens next week
It is just one week until ISPOR’s virtual 2020 conference goes live. The Annual ISPOR conference is scheduled to run, … read more »
